CancerNetwork Members: Login | Register
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
PATIENTS
NURSES
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Integrative Oncology

ONCOLOGY. Vol. 24 No. 1
INTEGRATIVE ONCOLOGY 

Omega-3

Complementary Therapies, Herbs, and Other OTC Agents

By Guest Editor Barrie Cassileth, PhD1 | January 18, 2010
1 Laurance S. Rockefeller Chair and Chief, Integrative Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York

Omega-3 fatty acids have gained popularity over the past decade as growing scientific evidence supports their use in preventing cardiovascular disease, depression, rheumatoid arthritis, and asthma, and in slowing cognitive decline. Because they are essential and cannot be synthesized in the human body, omega-3 fatty acids should be obtained through diet by consuming fish and nuts, or in supplemental form.

The American Heart Association recommends intake of fatty fish at least twice a week.

Patients taking anticoagulant or antiplatelet drugs should use caution, as omega-3 fatty acids can have additive effects.

ALSO KNOWN AS: Omegaven, Max-EPA

SUMMARY: Omega-3 fatty acids are essential compounds involved in several important physiologic processes. They are not synthesized in the body but can be obtained through diet or by taking dietary supplements. Fatty fish and nuts are excellent sources of omega-3.

There are three types of omega-3 fatty acids: alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid(Drug information on docosahexaenoic acid) (DHA). Following ingestion, ALA is converted to EPA and DHA, forms that are readily used by the body.

Omega-3 fatty acids have been extensively researched, and there is strong evidence of their effectiveness in preventing cardiovascular disease. Benefits were also seen in patients with depression, rheumatoid arthritis, cystic fibrosis, and systemic lupus erythematosus. In addition, omega-3 fatty acids confer neuroprotective effects by slowing cognitive decline in elderly individuals.[1]

The role of omega-3 in cancer prevention is inconclusive: Supplementation was shown to reduce risk of colon cancer,[2] but a systematic review of studies did not find a significant effect on lowering cancer incidence.[3] Further, higher intake of alpha-linolenic acid led to an increased risk of advanced prostate cancer in patients with low-grade disease.[4] More studies are needed.

ADVERSE REACTIONS: Fishy aftertaste,[2] loose stools, and nausea[5] have been reported following intake of large doses. Fish oil can have additive anticoagulant/antiplatelet effects.[6]

LAB INTERACTIONS: Omega-3 fatty acids reduce levels of alpha-tocopherol and beta-carotene.[2,7] High levels of omega-3 fatty acids may decrease triglyceride and increase LDL cholesterol levels.[8] Doses higher than 3 grams per day may increase bleeding time.[9]

TAKE HOME POINTS
• Consumption of omega-3 fatty acids helps prevent a range of medical problems such as heart disease, depression, rheumatoid arthritis, and asthma.
• The role of omega-3 in cancer prevention is inconclusive.
• Omega-3 fatty acids are abundant in fatty fish such as mackerel, lake trout, herring, sardines, albacore tuna, salmon, and in walnuts and flaxseed.
• Patients should discuss use of omega-3 supplements with their physicians because high doses can increase bleeding time.
For additional information visit the Memorial Sloan-Kettering Cancer Center Integrative Medicine Service website, “About Herbs” at http://www.mskcc.org/AboutHerbs.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





REFERENCES

1. Fetterman Jr JW, Zdanowicz MM: Therapeutic potential of n-3 polyunsaturated fatty acids in disease. Am J Health-Syst Pharm 66:1169-1179, 2009.

2. Anti M, Armelao F, Marra G, et al: Effects of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomas. Gastroenterology 107:1709-1718, 1994.

3. MacLean CH, Newberrt SJ, Mojica WA, et al: Effects of omega-3 fatty acids on cancer risk. JAMA 295:403-415, 2006.

4. Giovannucci E, Liu Y, Platz EA, et al: Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer 121:1571-1578, 2007.

5. Fugh-Berman A, Cott JM: Dietary supplements and natural products as psychotherapeutic agents. Psychosom Med 61:712-728, 1999.

6. Haller C, Kearney T, Bent S, et al: Dietary supplement adverse events: Report of a one-year poison center surveillance project. J Med Toxicol 4:84-92, 2008.

7. Holm T, Berge RK, Andreassen AK, et al: Omega-3 fatty acids enhance tumor necrosis factor-alpha levels in heart transplant recipients. Transplantation 72:706-711, 2001.

8. Farmer A, Montori V, Dinneen S, et al: Fish oil in people with type 2 diabetes mellitus. Cochrane Database Syst Rev CD003205, 2001.

9. Lewis CJ: Letter regarding dietary supplement health claim for omega-3 fatty acids and coronary heart disease. FDA Docket No. 91N-0103, October 31, 2000. Available at http://www.fda.gov/ohrms/dockets/DOCKETS/95s0316/95s-0316-Rpt0272-38-Appendix-D-Reference-F-FDA-vol205.pdf. Accessed December 21, 2009.


 
RELATED CONTENT

Green Tea (Camellia sinensis)
ONCOLOGY,  December 31, 2011
Flaxseed (Linum usitatissimum)
ONCOLOGY,  November 15, 2011
Coenzyme Q10
ONCOLOGY Nurse Edition,  October 19, 2011
Essiac
ONCOLOGY,  October 11, 2011
Ginkgo (Ginkgo biloba)
ONCOLOGY,  September 12, 2011
 
TOPIC INDEX

  • Bladder Cancer
  • Bone Metastases
  • Breast Cancer
  • CML
  • Colorectal Cancer
  • End-of-Life
  • GIST
  • Genetics Genomics
  • Gynecologic Cancers
  • Head & Neck Cancer
  • Integrative Oncology
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Nausea & Vomiting
  • Palliative Care
  • Pancreatic Cancer
  • Practice Management
  • Practice & Policy
  • Prostate Cancer
  • RCC
  • Skin Cancer
  • Triple-Negative Breast
  • Testicular Cancer


More Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Tax Schemes Every Physician Should Avoid
Ike Devji, JD, January 31, 2012
The next 60 days marks the final push to sell physicians across the United States tax plans of both good and questionable value.
Boosting Collections at Your Medical Practice: Whose Job Is It?
P.J. Cloud-Moulds, January 28, 2012
Embrace the relationship between your billing company and your medical practice staff.
Managing Difficult Medical Practice Employees
Shelly K. Schwartz, January 27, 2012
Tips for transforming immature staff members into great employees.
Prevent Physician Distraction When Using mHealth Technology
Aubrey Westgate, January 25, 2012
As more and more physicians use handheld mobile technology in their day-to-day work, some critics are raising concerns about “distracted doctoring.”
Can That Applicant Do the Job at Your Medical Practice?
Karen Zupko, January 25, 2012
If like many communities, yours has significant numbers of non-English speaking people with whom neither you nor your staff are able to converse, your practice is at a serious disadvantage.
 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Head and Neck Tumors
  • 46-Year-Old Woman Presents With Difficulty in Ambulation, and Swelling and Discoloration of Both Eyelids
  • Optimizing Outcomes of Advanced Prostate Cancer: Drug Sequencing and Novel Therapeutic Approaches
  • A 28-Year-Old Woman Presents With a Long-Standing History of Intermittently Painful “Bumps” on Both Her Shoulders and Upper Back
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • Evolution of Treatment Options for Patients With CRPC and Bone Metastases: Bone-Targeted Agents That Go Beyond Palliation of Symptoms to Improve Overall Survival
  • Ending the Shortage of Generic Oncology Drugs
  • Processed and Red Meat Consumption Linked to Slight Increase in Risk of Pancreatic Cancer
  • New Mutation May Act as Driver in Subset of Lung Cancer Patients
  • Could Aspirin Be a Viable Adjuvant Treatment for Cancer?
  • Advances and New Research in the Treatment of Kidney Cancer
  • New Way to Predict Prostate Cancer Severity—Size of Prostate
  • Vismodegib Granted FDA Approval for Treatment of Basal Cell Carcinoma
  • FDA Grants Approval to Axitinib for the Treatment of Advanced Renal Cell Carcinoma
  • Why BRAF-Mutated Colorectal Cancers Don't Respond to BRAF Inhibitors
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • When to Treat Myelodysplastic Syndromes
  • Are We Ready for Neoadjuvant Therapy in Potentially Resectable Pancreatic Cancer?
  • ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
  • PSA Screening for Prostate Cancer Put Into Question By the U.S. Preventive Services Task Force
  • When to Treat Myelodysplastic Syndromes
  • ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
  • Are We Ready for Neoadjuvant Therapy in Potentially Resectable Pancreatic Cancer?
  • Evolving Therapeutic Paradigms for Advanced Prostate Cancer
Click here to subscribe to our newsletter
 
JOB LISTINGS

Post a job

Powered by SearchMedica Jobs


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Integrative Oncology
Evidence on Integrative Oncology
Guidelines on Integrative Oncology
Patient Education on Integrative Oncology
Clinical Trials on Integrative Oncology
Practical Articles on Integrative Oncology
Research and Reviews on Integrative Oncology
All "Integrative Oncology" results


CancerNetwork on Facebook

 

CancerNetwork | CME LLC | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2012 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy